VALIANT LABORATORIES
Back to All Ratios
|
VALIANT LABORATORIES Last 5 Year Receivable days History
[Consolidated]
Mar2024 | Mar2023 | |
---|---|---|
Receivable days | 134.62 | 96.82 |
What is the latest Receivable days ratio of VALIANT LABORATORIES ?
Year | Receivable days |
---|---|
Mar2024 | 134.62 |
Mar2023 | 96.82 |
How is Receivable days of VALIANT LABORATORIES Trending?
Years | Receivable days | % Change | |
---|---|---|---|
Mar2024 | 134.62 | 39.04 | |
Mar2023 | 96.82 | - |
Other Financial Ratios of VALIANT LABORATORIES
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Receivable days ratio of peers of VALIANT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VALIANT LABORATORIES | ₹478.9 Cr | -7.9% | -15.9% | -29.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,466.0 Cr | 1.7% | 2% | -0.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,298.0 Cr | 0.4% | -2% | 37.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹127,538.0 Cr | 6% | 10.5% | 13.6% | Stock Analytics | |
CIPLA | ₹127,140.0 Cr | 6.8% | 4.6% | -0.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,500.0 Cr | 4.2% | 1.3% | -6.7% | Stock Analytics |
VALIANT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VALIANT LABORATORIES | -7.9% |
-15.9% |
-29.9% |
SENSEX | -1% |
-3.2% |
1.6% |
You may also like the below Video Courses